Recombinant swinepox virus for veterinary vaccine development

4Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Poxvirus-vectors have been widely used in vaccine development for several important human and animal diseases; some of these vaccines have been licensed and used extensively. Swinepox virus (SPV) is well suited to develop recombinant vaccines because of its large packaging capacity for recombinant DNA, its host range specifi city, and its ability to induce appropriate immune responses.

Cite

CITATION STYLE

APA

Fan, H. J., & Lin, H. X. (2016). Recombinant swinepox virus for veterinary vaccine development. In Methods in Molecular Biology (Vol. 1349, pp. 163–175). Humana Press Inc. https://doi.org/10.1007/978-1-4939-3008-1_11

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free